Historial de carrera de Craig C. Talluto
Antiguos cargos conocidos de Craig C. Talluto.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director de Operaciones | 28/05/2010 | 26/07/2012 |
Director Técnico/Científico/I+D | 04/11/2009 | 22/01/2013 | |
Corporate Officer/Principal | 28/05/2010 | 28/05/2010 | |
SYNERGY PHARMACEUTICALS INC | Director Técnico/Científico/I+D | 29/03/2011 | 15/05/2012 |
Corporate Officer/Principal | 15/07/2010 | 29/03/2011 |
Formación de Craig C. Talluto.
University of Miami | Doctorate Degree |
University of New Orleans | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Craig C. Talluto
- Experiencia